Narayana Hrudayalaya Reports 78.0% YoY Revenue Growth in Q1 FY27; Consolidated EBITDA Reaches ₹5,052 Mn

Narayana Hrudayalaya Reports 78.0% YoY Revenue Growth in Q1 FY27; Consolidated EBITDA Reaches ₹5,052 Mn​

Narayana Hrudayalaya Limited, a leading healthcare service provider, reported strong financial results for the first quarter (Q1 FY27) ended June 30, 2026. The company posted consolidated operating revenue of ₹ 26,836 Million, marking a significant year-on-year growth of 78.0%.

Consolidated EBITDA for the quarter stood at ₹ 5,052 Mn, reflecting a margin of 18.8%, which shows a 40.0% rise compared to Q1 FY26. Consolidated PAT also grew by 5.7% year-on-year, reaching ₹ 2,073 Mn.

The operational results highlight robust performance across various geographic segments.

Financial Performance Snapshot (Q1 FY27)​

Segment revenue data reveals continued growth in key markets:

Balance Sheet and Operational Highlights​

As of June 30, 2026, the company reported a net debt to equity ratio of 0.42. The company's total borrowings less Cash & Bank Balance and Investments amounted to INR 19,671 Mn. Foreign currency denominated debt includes US$ 115 Mn and GBP £150 Mn.

During the quarter, Narayana Hrudayalaya reported several significant operational advancements:

• Cardiac Care: The Narayana Institute of Cardiac Sciences in Bangalore conducted 2,137 cardiac surgeries in Q1 FY27. Furthermore, 19 Pulse Field Ablation procedures for Atrial Fibrillation were performed in June 2026 since the technology's launch in India.
• Robotic Surgery: The Narayana Hospital in Gurugram operationalized new technologies including the CUVIS Ortho Robotic System and the Thulium Laser System. Units across the network also carried out a wide spectrum of robotic surgeries, including Robotic CBD Exploration, Robot-assisted Hiatus & Ventral Hernia Repair + Paraumbilical Lump Excision, Robotic Simple Prostatectomy, and Robotic Cytoreductive Surgery.

Management Commentary​

Commenting on the quarterly results, Dr. Emmanuel Rupert, Managing Director and Group CEO of Narayana Hrudayalaya Limited, noted that the first quarter of FY27 showed a robust performance across all geographies. He credited India's continued growth to higher patient footfall, a focus on complex procedures, and underlying customer demand, which is supported by the Integrated Care ecosystem involving clinics and insurance platforms.

Regarding international operations, Dr. Rupert mentioned that the Cayman business continues performing well, backed by the One Health insurance platform. Furthermore, he stated that the newly acquired UK business remains stable as integration efforts progress toward completion from its erstwhile parent organization.

Conference Call Details​

The management of Narayana Hrudayalaya Limited will host a conference call to discuss the company's performance on Monday, August 3, 2026, at 03:00 PM IST.

NH Stock Price Movement​

Narayana Hrudayalaya Ltd. shares slipped by 2.9% on Friday, settling at ₹2029.2 after traders closed out the session. The stock saw significant movement amid 268,301 shares traded, following a period where it had previously hit its 52-week high.